Last ¥6,030 JPY
Change Today -50.00 / -0.82%
Volume 258.8K
2267 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
As of 1:00 AM 12/17/14 All times are local (Market data is delayed by at least 15 minutes).

yakult honsha co ltd (2267) Snapshot

Open
¥6,020
Previous Close
¥6,080
Day High
¥6,070
Day Low
¥6,020
52 Week High
11/25/14 - ¥6,930
52 Week Low
03/17/14 - ¥4,635
Market Cap
1.1T
Average Volume 10 Days
329.2K
EPS TTM
¥144.62
Shares Outstanding
175.9M
EX-Date
03/27/15
P/E TM
41.7x
Dividend
¥25.00
Dividend Yield
0.41%
Current Stock Chart for YAKULT HONSHA CO LTD (2267)

Related News

No related news articles were found.

yakult honsha co ltd (2267) Related Businessweek News

View More BusinessWeek News

yakult honsha co ltd (2267) Details

Yakult Honsha Co., Ltd., a probiotics company, primarily manufactures and sells food and beverage products. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others. The company offers food and beverages products comprising fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, including Elplat, a cancer chemotherapeutic agent for the treatment of colorectal cancer; Levofolinate Yakult, an activated folic acid drug; Gemcitabine Yakult, an antineoplastic antimetabolite; recombinant DNA G-CSF chemotherapy preparation Neu-up; Imatinib yakult, a generic antineoplastic drug; and Campto, an active pharmaceutical ingredient. The company is also developing Elplat for gastric cancer; PR610, a hypoxia activated pro drug; Perifosine, a PI3K/Akt inhibitor; Resminostat, an oral HDAC inhibitor; LIV-2008, which are humanized monoclonal anticancer antibodies; antibody biosimilars; and Zoledronic acid intravenous drip, a generic drug for bone lesions. In addition, it offers cosmetics and skin care products under the Parabio, Revecy, and Revecy White brand names; and BECYCLE Lift Repair Essence, which adds firmness and resilience to the skin, as well as operates and manages the Tokyo Yakult Swallows, a professional baseball team. The company was founded in 1935 and is headquartered in Tokyo, Japan.

20,492 Employees
Last Reported Date: 06/26/14
Founded in 1935

yakult honsha co ltd (2267) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

yakult honsha co ltd (2267) Key Developments

Danone Reportedly Planning To Sell Yakult Stake

Danone (ENXTPA:BN) is planning to sell a stake in Yakult Honsha Co. Ltd. (TSE:2267). Bloomberg reported that Danone may sell 20% stake in Yakult Honsha for around $2 billion. According to the news report which citied people close to the matter, officials for Danone and Yakult were not immediately available to comment on the report. It further added that Danone has held internal discussions about a possible sale and the talks were at an early stage and no final decision has been made.

Yakult Honsha Co. Ltd. Announces Consolidated and Non-Consolidated Earnings Results for the Second Quarter Ended September 30, 2014; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015

Yakult Honsha Co. Ltd. announced consolidated and non-consolidated earnings results for the second quarter ended September 30, 2014. For the quarter, on consolidated basis, the company reported net sales of ¥180,498 million against ¥172,666 million a year ago. Operating income was ¥16,644 million against ¥15,432 million a year ago. Ordinary income was ¥20,736 million against ¥19,224 million a year ago. Income before income taxes and minority interests was ¥20,615 million against ¥19,092 million a year ago. Net income was ¥12,014 million against ¥10,655 million a year ago. Cash flows from operating activities ¥23,331 million against ¥21,314 million a year ago. For the second quarter, non-consolidated basis, the company reported net sales of ¥89,164 million against ¥91,409 million a year ago. Operating income was ¥1,386 million against ¥1,214 million a year ago. Ordinary income was ¥5,604 million against ¥4,822 million a year ago. Net income was ¥4,523 million against ¥3,796 million a year ago. Income before income taxes was ¥5,447 million against ¥4,862 million a year ago. The company provided earnings guidance for the fiscal year ending March 31, 2015. On consolidated basis, the company expects net sales of ¥370,000 million. The company expects operating income of ¥34,500 million, ordinary income of JPY 42,000 million and net income of JPY 24,000 million.

Yakult Honsha Co. Ltd. to Report Q2, 2015 Results on Nov 07, 2014

Yakult Honsha Co. Ltd. announced that they will report Q2, 2015 results on Nov 07, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2267:JP ¥6,030.00 JPY -50.00

2267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 3,360 INR -63.20
BioGaia AB kr177.50 SEK -3.50
Mead Johnson Nutrition Co $98.58 USD +3.13
Probi AB kr58.25 SEK -0.50
View Industry Companies
 

Industry Analysis

2267

Industry Average

Valuation 2267 Industry Range
Price/Earnings 39.3x
Price/Sales 2.6x
Price/Book 3.3x
Price/Cash Flow 41.8x
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact YAKULT HONSHA CO LTD, please visit www.yakult.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.